Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting
... (51.8%), leukopenia (48.2%), diarrhea (36.4%),
fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%),
neutropenia (32.3%) and
ecchymosis (30.5%). Other adverse reactions
included dizziness (18.6%), chest pain (16.4%), febrile neutropenia
(16.4%), myalgia (15.9%), injection site ...
Ecchymosis in Medical Technology
Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
... (51.8%), leukopenia (48.2%), diarrhea (36.4%),
fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%),
neutropenia (32.3%) and
ecchymosis (30.5%). Other adverse reactions
included dizziness (18.6%), chest pain (16.4%), febrile neutropenia
(16.4%), myalgia (15.9%), injection site ...
Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
... (51.8%), leukopenia (48.2%), diarrhea (36.4%),
fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%),
neutropenia (32.3%) and
ecchymosis (30.5%). Other adverse reactions
included dizziness (18.6%), chest pain (16.4%), febrile neutropenia
(16.4%), myalgia (15.9%), injection site ...
MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
... (51.8%), leukopenia (48.2%), diarrhea (36.4%),
fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%),
neutropenia (32.3%) and
ecchymosis (30.5%). Other adverse reactions
included dizziness (18.6%), chest pain (16.4%), febrile neutropenia
(16.4%), myalgia (15.9%), injection site ...
Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
... (51.8%), leukopenia (48.2%), diarrhea (36.4%),
fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%),
neutropenia (32.3%) and
ecchymosis (30.5%). Other adverse reactions
included dizziness (18.6%), chest pain (16.4%), febrile neutropenia
(16.4%), myalgia (15.9%), injection site ...
Clinical Data Reported on Vidaza in Hematologic Malignancies and
Advanced Solid Tumors
... erythema (35.0%), constipation (33.6%), neutropenia (32.3%)
and
ecchymosis (30.5%). Other adverse reactions included dizziness
(18.6%), chest pain ... site erythema (35.0%), constipation (33.6%), neutropenia
(32.3%) and
ecchymosis (30.5%). Other adverse reactions included
dizziness (18.6%), chest pain ...
Ecchymosis in Medical Dictionary
Aging skin
... Source: First DataBank, Inc. Bruise (
ecchymosis ) Birth (petechiae in the newborn) Aging skin (
ecchymosis ) Idiopathic thrombocytopenic purpura ... purpura ( purpura ) Leukemia ( purpura and
ecchymosis ) Drugs ... medical treatment , such as ...
Ecchymosis
...
ecchymosis , or more commonly known as a black eye ," ... tissue around the eye to become bruise d.
ecchymosis A small bruise caused by blood leaking from ... or mucous membrane s. echocardiography ...
ecchymosis , or discoloration of the skin , occurs from ...
Adenoma
... may be performed: Multi ple endocrine neoplasia I (MEN I) Multi ple endocrine neoplasia II (MEN II) ... ecchymoma; ecchymose; ecchymosed;
ecchymosis ; ecchymotic; ecchymotic mask; eccle; ecclesia; ecclesiological; ecclesiologist; ecclesiology; Eccleston; eccoriate; eccrine; eccrine acrospiroma; ...
Eardrum
... reach your middle ear and cause infection . eardrum The tympanic membrane that's visible in the ear. It vibrates in response to sound waves.
ecchymosis ... Eardrum Repair - Series See all Pictures & Images Overview & Considerations ... The eardrum is a thin membrane that ...
Epstein
... people. It has been associated with certain cancer s, including Burkitt's lymphoma , immunoblastic lymphoma , and nasopharyngeal carcinoma .
ecchymosis ... Epstein -Barr Virus May Trigger Multiple Sclerosis Molecule May Drive Multiple Sclerosis -Linked Disorder Multiple Sclerosis : ...
Epstein-barr Virus
... people. It has been associated with certain cancer s, including Burkitt's lymphoma , immunoblastic lymphoma , and nasopharyngeal carcinoma .
ecchymosis ... Epstein-Barr Virus May Trigger Multiple Sclerosis Molecule May Drive Multiple Sclerosis -Linked Disorder Multiple Sclerosis : ...
Palpation
... left ankle. There was significant pain upon palpation over both the top and bottom of the left ankle. vessels may have ruptured , causing
ecchymosis , a purple discoloration of the skin . If the bone fragments have separated enough to distort the normal contour of the arm, there will be visible ...
Panic
... breathing rapidly can make you feel panic ked. The tym panic membrane that's visible in the ear. It vibrates in response to sound waves.
ecchymosis A collection of blood in the tissue s causing a black and blue, or yellow, area. Kartush tym panic membrane (TM) patcherSee Xomed Kartush ...
Stein
... people. It has been associated with certain cancer s, including Burkitt's lymphoma , immunoblastic lymphoma , and nasopharyngeal carcinoma .
ecchymosis ... EP STEIN BARR VIRUS ( Chronic Fatigue Syndrome ) SYMPTOMS"Recurrent upper- respiratory tract infections , exhaustion, extreme fatigue ...
Tympanic membrane
... airplane ascents and descents. Valsalva Maneuver ... The tympanic membrane that's visible in the ear. It vibrates in response to sound waves.
ecchymosis A collection of blood in the tissue s causing a black and blue, or yellow, area. Kartush tympanic membrane (TM) patcherSee Xomed Kartush ...
More>>
Ecchymosis in Biological Technology
EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes
... (51.8%), leukopenia (48.2%), diarrhea (36.4%),
fatigue (35.9%), injection site erythema (35.0%), constipation (33.6%),
neutropenia (32.3%) and
ecchymosis (30.5%). Other adverse reactions
included dizziness (18.6%), chest pain (16.4%), febrile neutropenia
(16.4%), myalgia (15.9%), injection site ...
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
... (51.8%), leukopenia (48.2%), diarrhea (36.4%), fatigue
(35.9%), injection site erythema (35.0%), constipation (33.6%), neutropenia
(32.3%) and
ecchymosis (30.5%). Other adverse reactions included dizziness
(18.6%), chest pain (16.4%), febrile neutropenia(16.4%), myalgia (15.9%),
injection site reaction ...